Skip to main content
UCB's Global Corporate Website
instagram
facebook
twitter
youtube
linkedin
rss
Listen
14 May 2009
Partnership unites UCB with consumer product innovator OXO®
Read More
14 May 2009
UCB's CIMZIA® (certolizumab pegol) approved by the U.S. FDA for adult patients suffering from moderate to severe rheumatoid arthritis
Read More
8 May 2009
UCB seeking to acquire remaining Schwarz Pharma shares
Read More
30 Apr 2009
Statement of the CEO of UCB at the AGM: UCB executing on its strategy
Read More
30 Apr 2009
UCB focuses on new product launches
Read More
28 Apr 2009
UCB announces first results from Phase III brivaracetam studies in epilepsy
Read More
3 Mar 2009
UCB: Full Year 2008 Financial Results
Read More
20 Feb 2009
UCB announces top-line outcomes for proof-of-concept studies
Read More
20 Feb 2009
UCB to divest Equasym®
Read More
19 Feb 2009
UCB plans new biologics pilot plant in Braine-l'Alleud, Belgium
Read More
Pagination
First page
Previous page
‹ Previous
…
Page
84
Page
85
Page
86
Page
87
Current page
88
Page
89
Page
90
Page
91
Page
92
…
Next page
Next ›
Last page
Subscribe to
Choose a Country
Global Site – English
Australia – English
België – Engels
Belgique – Anglais
Brasil – Português
България – Български
Canada – English
Canada – Français
中国 – 中文
Česká Republika – Angličtina
Danmark – Engelsk
Deutschland – Deutsch
France – Français
España – Español
Ελλάδα – Ελληνικά
India – English
Ireland – English
Italia – Inglese
日本 – 日本語
한국 – 한국어
Luxembourg – Anglais
Luxemburg – Engels
Magyarország – Angol
México & Latinoamérica – Español
Nederland – Engels
New Zealand – English
Norge – Engelsk
Österreich – Deutsch
Polska – Polski
Portugal – español y portugués
România – Engleză
Россия – Русский
Slovensko – Anglický
Suomi – Englanti
Sverige – Engelska
Schweiz – Deutsch
Türkiye – Türkçe
Україна – Англійська
United Kingdom – English
U.S.A. – English
×
instagram
facebook
twitter
youtube
linkedin
rss